• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Paroxetine a good non-hormonal option for hot flashes

byDenise PongandLeah Hawkins Bressler, MD, MPH
April 10, 2016
in Obstetrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Paroxetine use was associated with decreased frequency of hot flashes and lower composite vasomotor symptom (VMS) severity score.

2. Women randomized to receive paroxetine were more likely to experience nausea and dizziness than those randomized to placebo.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Hot flashes, which may include symptoms of heat, sweating and palpitations followed by chills and shivering, are the most common complaint among women going through menopause. VMS are experienced by approximately 80% of women in the United States, most commonly in the late menopause and early postmenopausal stages. While VMS can significantly impair quality of life, only a minority of women seek treatment. Hormonal therapy with estrogen has been shown to decrease VMS but may increase risk for cardiovascular disease and breast cancer. As such, hormonal therapy is only recommended for short-term use and may not be a suitable choice for women with a prior history of heart disease, stroke or breast cancer. Non-hormonal treatment options include selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor antidepressants, as well as anti-epileptic medications such as gabapentin. In the present work, authors pooled data from 6 randomized controlled trials (RCTs) and found that paroxetine was effective in reducing the frequency and severity of VMS; they also found that use of the drug was associated with nausea and dizziness.

Strengths of the study were inclusion of data only from randomized placebo-controlled trials. The meta-analysis was limited primarily by variability in paroxetine dosing and formulation across studies and limited duration of follow-up. Additional RCTs are needed to identify the optimal paroxetine dose and formulation that effectively treats VMS over the long-term while minimizing adverse effects.

Click to read the study in BJOG

Click to read an accompanying editorial in BJOG

RELATED REPORTS

Endometriosis associated with early natural menopause

Paroxetine does not improve left ventricle ejection fraction at 12 weeks post-anterior myocardial infarction

Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms

Relevant Reading: A review of paroxetine for the treatment of vasomotor symptoms

In-Depth [systematic review and meta-analysis]: This systematic review evaluated the impact and safety of paroxetine use in the treatment of VMS in peri- and post- menopausal women with moderate to severe VMS in placebo-controlled RCTs. The meta-analysis included 5 articles and 6 RCTs, with a total of 1571 participants. The primary outcomes of interest were frequency of VMS, daily composite VMS severity score, and frequency of nausea. Secondary outcomes included duration of VMS and frequency of adverse side effects such as somnolence, dry mouth and dizziness.

Paroxetine use was associated with decreased frequency of VMS at 4 weeks (mean difference 8.86 per week, CI 5.69-12.04) and 12 weeks (mean diff 7.36 per week, CI 4.25-10.46). The daily composite VMS severity score was also lower among patients randomized to receive paroxetine at 4 weeks (p < 0.00001) and 12 weeks (p < 0.009). Nausea and dizziness were more frequently experienced among women using paroxetine (RR 2.45, CI 1.29-4.66; RR 2.44, CI 1.02-5.85 respectively).

Image: CC/wiki/MorgueFile

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: menopauseparoxetinevasomotor symptoms
Previous Post

Infertility linked to higher birth defect risk

Next Post

Eating fresh fruit decreased the risk of cardiovascular disease in Chinese adults: The China Kadoorie Biobank Study

RelatedReports

Early language exposure is predictive of language skills and IQ in school-age children
Chronic Disease

Endometriosis associated with early natural menopause

January 24, 2022
Reinnervation of cardiac infarcts decreases subsequent arrhythmia incidence [PreClinical]
Cardiology

Paroxetine does not improve left ventricle ejection fraction at 12 weeks post-anterior myocardial infarction

November 8, 2021
Early palliative care may improve survival in advanced cancer
Chronic Disease

Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms

October 14, 2021
#VisualAbstract Menopausal hormone therapy was not associated with risk of cutaneous melanoma
StudyGraphics

#VisualAbstract Menopausal hormone therapy was not associated with risk of cutaneous melanoma

July 22, 2021
Next Post
Fruit consumption among US youth differs by age, race

Eating fresh fruit decreased the risk of cardiovascular disease in Chinese adults: The China Kadoorie Biobank Study

Significant healthcare disparities exist between rural and non-rural children

Significant healthcare disparities exist between rural and non-rural children

Cardiac mortality paradoxically lower during times of national cardiology conferences

2 Minute Medicine Rewind April 11, 2016

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
  • Gratitude-focused writing may improve mental wellness during periods of chronic stress
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.